Advocacy
Learn more about the Association's advocacy efforts to ensure patient
access to therapies.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Jul 13, 2021
Europe Needs to Collect More Plasma
Plasma-derived medicinal products PDMPs), derived from human plasma from healthy donors, are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64539bb0b145bb5b857f53a7_EU%20Position%20paper_Europe%20needs%20to%20collect%20more%20plasma.pdf
Jul 13, 2021
Europe Needs to Collect More Plasma
Plasma-derived medicinal products PDMPs), derived from human plasma from healthy donors, are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64539bb0b145bb5b857f53a7_EU%20Position%20paper_Europe%20needs%20to%20collect%20more%20plasma.pdf
Mar 31, 2021
PPTA Supports California AB 392
The Plasma Protein Therapeutics Association (PPTA) would like to thank you for authoring Assembly Bill 392.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f688a121567c7026889d_PPTA%20Supports%20AB%20392%20Nazarian.pdf
Mar 31, 2021
PPTA Supports California AB 392
The Plasma Protein Therapeutics Association (PPTA) would like to thank you for authoring Assembly Bill 392.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f688a121567c7026889d_PPTA%20Supports%20AB%20392%20Nazarian.pdf
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Sep 23, 2020
U.S. International Trade Commission Testimony on COVID-19 Related Goods
Oral Testimony of Amy C. Efantis, President & CEO, Plasma Protein Therapeutics Association Hearing on COVID-19 Related Goods: Conditions in the U.S. Industry and Key Supply Chains U.S. International Trade Commission.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa440e4694729840b893_PPTA_USITC_Testimony-COVID-19_.pdf
Sep 23, 2020
U.S. International Trade Commission Testimony on COVID-19 Related Goods
Oral Testimony of Amy C. Efantis, President & CEO, Plasma Protein Therapeutics Association Hearing on COVID-19 Related Goods: Conditions in the U.S. Industry and Key Supply Chains U.S. International Trade Commission.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa440e4694729840b893_PPTA_USITC_Testimony-COVID-19_.pdf
No results found